Form 4 for BTSG BrightSpring Health Services, Inc.
Accepted 2024-01-30 00:00:00 ET · period of report 2024-01-25 · accession 0000950170-24-008832 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-30 | 2024-01-26 | BTSG | Nalley Lisa A | See Remarks | A - Grant | $0.00 | +96.5K | 99.6K | +3,072% | $0 |
| DM | 2024-01-30 | 2024-01-25 | BTSG | Nalley Lisa A | See Remarks | A - Grant | $0.00 | +74.3K | 11.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-26 | A | A | 96,454 | $0.00 | 99,594 | D | — | — | |
| 2 | Derivative | Stock Options (Right to Buy) | 2024-01-25 | A | A | 35,006 | $0.00 | 35,006 | D | $13.00 · — to 2034-01-25 | 35,006 Common Stock | (F4) Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. |
| 3 | Derivative | Stock Options (Right to Buy) | 2024-01-25 | A | A | 35,331 | $0.00 | 105,993 | D | $6.37 · — to 2029-09-24 | 35,331 Common Stock | (F2) Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock, which became effective on January 25, 2024 (the "Stock Split"). Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. |
| 4 | Derivative | Stock Options (Right to Buy) | 2024-01-25 | A | A | 3,925 | $0.00 | 11,777 | D | $7.01 · — to 2030-05-12 | 3,925 Common Stock | (F3) Options acquired represent options originally granted on May 12, 2020, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing May 12, 2021. Reflects the Stock Split. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. |